Purchase of AAA Netspot - Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours

A Contract Award Notice
by THE ROYAL MARSDEN NHS FOUNDATION TRUSTS

Source: Find a Tender
Type: Contract (Goods)
Duration: not specified
Value: £475K

Sector: HEALTH
Published: 15 Apr 2021
Delivery: not specified
Deadline: n/a

Concepts

Location

London:

Geochart for 1 buyers and 2 suppliers

1 buyer

Royal Marsden NHS Trusts London

1 supplier

Advance Accelerator Applications London

Description

AAA Netspot is a Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours

Total Quantity or Scope

The Royal Marsden Hospital NHS Foundation Trust needs to purchase AAA Netspot vials which is a Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours

Award Detail

1	Advance Accelerator Applications (London) Reference: 007875-2021-1 Value: £475,200 [share] Awarded to group of suppliers.
2	Advance Accelerator Applications (London) Reference: 007875-2021-1 Value: £475,200 [share] Awarded to group of suppliers.

CPV Codes

33000000 - Medical equipments, pharmaceuticals and personal care products

Indicators

Legal Justification

AAA Netspot vials is a Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours. A radioactive diagnostic agent for positron emission tomography (PET) imaging of somatostatin receptor overexpression in adult patients with confirmed or suspected somatostatin receptor positive neuroendocrine tumors (NETs) for localizing primary tumours and their metastases. This innovative technology supports a more accurate diagnosis and staging of NETs and a more tailored treatment plan